» Articles » PMID: 37742646

Impact of Eating a Carbohydrate-Restricted Diet on Cortical Atrophy in a Cross-Section of Amyloid Positive Patients with Alzheimer's Disease: A Small Sample Study

Abstract

Background: A carbohydrate-restricted diet aimed at lowering insulin levels has the potential to slow Alzheimer's disease (AD). Restricting carbohydrate consumption reduces insulin resistance, which could improve glucose uptake and neural health. A hallmark feature of AD is widespread cortical thinning; however, no study has demonstrated that lower net carbohydrate (nCHO) intake is linked to attenuated cortical atrophy in patients with AD and confirmed amyloidosis.

Objective: We tested the hypothesis that individuals with AD and confirmed amyloid burden eating a carbohydrate-restricted diet have thicker cortex than those eating a moderate-to-high carbohydrate diet.

Methods: A total of 31 patients (mean age 71.4±7.0 years) with AD and confirmed amyloid burden were divided into two groups based on a 130 g/day nCHO cutoff. Cortical thickness was estimated from T1-weighted MRI using FreeSurfer. Cortical surface analyses were corrected for multiple comparisons using cluster-wise probability. We assessed group differences using a two-tailed two-independent sample t-test. Linear regression analyses using nCHO as a continuous variable, accounting for confounders, were also conducted.

Results: The lower nCHO group had significantly thicker cortex within somatomotor and visual networks. Linear regression analysis revealed that lower nCHO intake levels had a significant association with cortical thickness within the frontoparietal, cingulo-opercular, and visual networks.

Conclusions: Restricting carbohydrates may be associated with reduced atrophy in patients with AD. Lowering nCHO to under 130 g/day would allow patients to follow the well-validated MIND diet while benefiting from lower insulin levels.

Citing Articles

Automated brain segmentation and volumetry in dementia diagnostics: a narrative review with emphasis on FreeSurfer.

Khadhraoui E, Nickl-Jockschat T, Henkes H, Behme D, Muller S Front Aging Neurosci. 2024; 16:1459652.

PMID: 39291276 PMC: 11405240. DOI: 10.3389/fnagi.2024.1459652.

References
1.
Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

2.
McEwen S, Merrill D, Bramen J, Porter V, Panos S, Kaiser S . A systems-biology clinical trial of a personalized multimodal lifestyle intervention for early Alzheimer's disease. Alzheimers Dement (N Y). 2021; 7(1):e12191. PMC: 8290633. DOI: 10.1002/trc2.12191. View

3.
Albers M, Gilmore G, Kaye J, Murphy C, Wingfield A, Bennett D . At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimers Dement. 2014; 11(1):70-98. PMC: 4287457. DOI: 10.1016/j.jalz.2014.04.514. View

4.
Jovicich J, Czanner S, Greve D, Haley E, van der Kouwe A, Gollub R . Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage. 2005; 30(2):436-43. DOI: 10.1016/j.neuroimage.2005.09.046. View

5.
Dhana K, James B, Agarwal P, Aggarwal N, Cherian L, Leurgans S . MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults. J Alzheimers Dis. 2021; 83(2):683-692. PMC: 8480203. DOI: 10.3233/JAD-210107. View